Adaptive Biotechnologies (ADPT) Change in Inventory (2018 - 2026)

Adaptive Biotechnologies has disclosed Change in Inventory across 9 years of filings, most recently posting -$561000.0 for Q2 2026.

• In Q2 2026, Change in Inventory fell 490.53% year-over-year to -$561000.0; the TTM figure through Jun 2026 stood at $2.1 million (up 138.82% YoY), while the FY2025 annual figure was $998000.0, up 118.58% from the prior year.
• Change in Inventory came in at -$561000.0 for Q2 2026 at Adaptive Biotechnologies, down from $1.3 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $6.6 million in Q1 2023 to a low of -$4.0 million in Q4 2023.
• Average Change in Inventory over 5 years is -$88833.3, with a median of -$68500.0 recorded in 2022.
• The largest YoY upside for Change in Inventory was 1358.46% in 2024 against a maximum downside of 721.61% in 2024.
• Over 5 years, Change in Inventory stood at -$3.0 million in 2022, then plunged by 31.3% to -$4.0 million in 2023, then gained by 14.96% to -$3.4 million in 2024, then jumped by 100.3% to $10000.0 in 2025, then plunged by 5710.0% to -$561000.0 in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were -$561000.0 in Q2 2026, $1.3 million in Q1 2026, and $10000.0 in Q4 2025.